246 related articles for article (PubMed ID: 33830628)
1. CD248 enhances tissue factor procoagulant function, promoting arterial and venous thrombosis in mouse models.
Kapopara PR; Safikhan NS; Huang JL; Meixner SC; Gonzalez K; Loghmani H; Ruf W; Mast AE; Lei V; Pryzdial ELG; Conway EM
J Thromb Haemost; 2021 Aug; 19(8):1932-1947. PubMed ID: 33830628
[TBL] [Abstract][Full Text] [Related]
2. The endothelial protein C receptor supports tissue factor ternary coagulation initiation complex signaling through protease-activated receptors.
Disse J; Petersen HH; Larsen KS; Persson E; Esmon N; Esmon CT; Teyton L; Petersen LC; Ruf W
J Biol Chem; 2011 Feb; 286(7):5756-67. PubMed ID: 21149441
[TBL] [Abstract][Full Text] [Related]
3. [Inactivated factor VII exercises a powerful antithrombotic activity in an experimental model of recurrent arterial thrombosis].
Ragni M; Golino P; Cirillo P; Pascucci I; Scognamiglio A; Ravera A; Esposito N; Battaglia C; Guarino A; Chiariello M
Cardiologia; 1996 Jan; 41(1):51-8. PubMed ID: 8697470
[TBL] [Abstract][Full Text] [Related]
4. The antithrombotic and anti-inflammatory effects of BCX-3607, a small molecule tissue factor/factor VIIa inhibitor.
Arnold CS; Parker C; Upshaw R; Prydz H; Chand P; Kotian P; Bantia S; Babu YS
Thromb Res; 2006; 117(3):343-9. PubMed ID: 16378835
[TBL] [Abstract][Full Text] [Related]
5. A soluble tissue factor mutant is a selective anticoagulant and antithrombotic agent.
Kelley RF; Refino CJ; O'Connell MP; Modi N; Sehl P; Lowe D; Pater C; Bunting S
Blood; 1997 May; 89(9):3219-27. PubMed ID: 9129026
[TBL] [Abstract][Full Text] [Related]
6. Role of the Gla and first epidermal growth factor-like domains of factor X in the prothrombinase and tissue factor-factor VIIa complexes.
Thiec F; Cherel G; Christophe OD
J Biol Chem; 2003 Mar; 278(12):10393-9. PubMed ID: 12529356
[TBL] [Abstract][Full Text] [Related]
7. Direct Amplification of Tissue Factor:Factor VIIa Procoagulant Activity by Bile Acids Drives Intrahepatic Coagulation.
Baker KS; Kopec AK; Pant A; Poole LG; Cline-Fedewa H; Ivkovich D; Olyaee M; Woolbright BL; Miszta A; Jaeschke H; Wolberg AS; Luyendyk JP
Arterioscler Thromb Vasc Biol; 2019 Oct; 39(10):2038-2048. PubMed ID: 31412737
[TBL] [Abstract][Full Text] [Related]
8. Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa.
Camerer E; Huang W; Coughlin SR
Proc Natl Acad Sci U S A; 2000 May; 97(10):5255-60. PubMed ID: 10805786
[TBL] [Abstract][Full Text] [Related]
9. The N-terminal epidermal growth factor-like domain in factor IX and factor X represents an important recognition motif for binding to tissue factor.
Zhong D; Bajaj MS; Schmidt AE; Bajaj SP
J Biol Chem; 2002 Feb; 277(5):3622-31. PubMed ID: 11723140
[TBL] [Abstract][Full Text] [Related]
10. BMS-593214, an active site-directed factor VIIa inhibitor: enzyme kinetics, antithrombotic and antihaemostatic studies.
Wong PC; Luettgen JM; Rendina AR; Kettner CA; Xin B; Knabb RM; Wexler R; Priestley ES
Thromb Haemost; 2010 Aug; 104(2):261-9. PubMed ID: 20589312
[TBL] [Abstract][Full Text] [Related]
11. Evolutionary conservation of the allosteric activation of factor VIIa by tissue factor in lamprey.
Beeler DL; Aird WC; Grant MA
J Thromb Haemost; 2018 Apr; 16(4):734-748. PubMed ID: 29418058
[TBL] [Abstract][Full Text] [Related]
12. A novel therapeutic approach combining human plasma-derived Factors VIIa and X for haemophiliacs with inhibitors: evidence of a higher thrombin generation rate in vitro and more sustained haemostatic activity in vivo than obtained with Factor VIIa alone.
Tomokiyo K; Nakatomi Y; Araki T; Teshima K; Nakano H; Nakagaki T; Miyamoto S; Funatsu A; Iwanaga S
Vox Sang; 2003 Nov; 85(4):290-9. PubMed ID: 14633255
[TBL] [Abstract][Full Text] [Related]
13. Herpes simplex virus type 1-encoded glycoprotein C enhances coagulation factor VIIa activity on the virus.
Sutherland MR; Friedman HM; Pryzdial EL
Thromb Haemost; 2004 Nov; 92(5):947-55. PubMed ID: 15543320
[TBL] [Abstract][Full Text] [Related]
14. Formation of tissue factor-factor VIIa-factor Xa complex promotes cellular signaling and migration of human breast cancer cells.
Jiang X; Bailly MA; Panetti TS; Cappello M; Konigsberg WH; Bromberg ME
J Thromb Haemost; 2004 Jan; 2(1):93-101. PubMed ID: 14717972
[TBL] [Abstract][Full Text] [Related]
15. Factor VIIa-mediated tenase function on activated platelets under flow.
Goel MS; Diamond SL
J Thromb Haemost; 2004 Aug; 2(8):1402-10. PubMed ID: 15304047
[TBL] [Abstract][Full Text] [Related]
16. Tissue factor pathway inhibitor inhibits aortic smooth muscle cell migration induced by tissue factor/factor VIIa complex.
Sato Y; Asada Y; Marutsuka K; Hatakeyama K; Kamikubo Y; Sumiyoshi A
Thromb Haemost; 1997 Sep; 78(3):1138-41. PubMed ID: 9308767
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of tissue factor:factor VIIa-catalyzed factor IX and factor X activation by TFPI and TFPI constructs.
Peraramelli S; Thomassen S; Heinzmann A; Rosing J; Hackeng TM; Hartmann R; Scheiflinger F; Dockal M
J Thromb Haemost; 2014 Nov; 12(11):1826-37. PubMed ID: 25163770
[TBL] [Abstract][Full Text] [Related]
18. Factor VIIa-induced interaction with integrin controls the release of tissue factor on extracellular vesicles from endothelial cells.
Rothmeier AS; Versteeg HH; Ruf W
J Thromb Haemost; 2019 Apr; 17(4):627-634. PubMed ID: 30740873
[TBL] [Abstract][Full Text] [Related]
19. A single-domain antibody that blocks factor VIIa activity in the absence but not presence of tissue factor.
Ferrière S; Kawecki C; Ottavi JF; Denis CV; Kauskot A; Christophe OD; Lenting PJ
J Thromb Haemost; 2019 Dec; 17(12):2035-2046. PubMed ID: 31423724
[TBL] [Abstract][Full Text] [Related]
20. A serine loop in tissue factor mediates substrate selectivity by the tissue factor-factor VIIa complex.
Birkle F; Morrissey JH
J Thromb Haemost; 2021 Jan; 19(1):75-84. PubMed ID: 32885882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]